“a strong trend”

Frequency of FcγRIII + AMs showed a strong trend toward correlation with SIV-specific ADP, and at 2-wpi FcγRIII expression negatively correlated with viral load ( r = −0.6819; p = 0.0013), suggesting a contribution to viremia control.

Three days later, the 30 and 100 mg/kg doses induced 40% and 59% tumor growth inhibition, respectively (p = 0.030 (this p value represents a strong trend) and p = 0.002, respectively).

The analysis of steroid levels in patients showed the following trends: Unconjugated steroids: A strong trend towards lower levels was found (n = 12 lower, n = 6 unchanged, n = 1 higher, p = 0.002).

A strong trend (before and after adjusting for multiple testing: p = 0.002 and p = 0.059) was observed for SUVmax within non-PCa-PET after applying the LBP filter.

Lungs of pups in P had a significantly lower proportion of aerated lung volume ( p = 0.0001), with significant posthoc differences on day 3/day 0 and day 5/day 2, and a strong trend towards less aerated volume on 7/day 4 ( p = 0.0022, p = 0.0282 and p = 0.0504 respectively).

In this case, there is a strong trend for the similarity to decrease with increasing field-to-barrier distance, as if near fields translate along with the barrier (r = −0.52, df = 28, P = 0.003).

Finally, at 30 degrees to the right, surprised faces were recognized significantly better than disgusted faces ( t (13) = 4.53, p = .0006; d = 1.21; Mean Surprised = 0.61, Mean Disgusted = -.03) while a strong trend was present for happy faces to be better recognized than disgusted faces which did not survive correction ( t (13) = 3.64, p = .003; d = .97; Mean Happy = 0.71, Mean Disgusted = -.03).

Suppressed expression of BAP1 occurred in 22 GBC cases (46.8%) and showed a strong trend toward a worse median survival time of 13.3 months (95% CI, 17.6–62.6) (p = 0.0034).

However, there was a strong trend for greater absolute sputum eosinophil count in paucigranulocytic asthmatics versus healthy subjects ( p = 0.005).

By contrast, the effect of the [obtained outcome x group] interaction showed a strong trend after Bonferroni correction towards negative outcomes (β = 0.04, p<0.005), confirming that RRMS patients rated negative outcomes less negatively than the controls.

Results of the ordinal logistic analysis showed a strong trend toward lower breast density with higher BMI at the start ( P < 0.005) and also a trend toward lower breast density categories with BMI increased over time ( P < 0.05).

A significant interaction with gene status was found in left amygdala and a strong trend in right amygdala resulted from PSCs failing to show the expected positive correlation with negative feedback ( T = 4.02; p = 0.005; at x , y , z = −18, −6, −12 and T = 3.37; p = 0.06 at x , y , z = 18, −8, −14; Fig. 2 ).

During low depolarization states, latency to first spike was decreased in all MSNs and D2-MSNs, with a strong trend toward reduction in D1-MSNs ( Figures 2 H and S3 A–S3C; all MSNs p = 0.0057, D1-MSNs p = 0.0626, and D2-MSNs p = 0.0295).

The primacy/recency ratio increased in parallel with omnibus scores [ r = 0.25, t (189) = 3.55, p < 0.0005] and, consistent with previous results (Capitani et al., 1992 ; Golomb et al., 2008 ), showed a strong trend toward decline with increasing age [ r = −0.20, t (189) = −2.81, p < 0.006].

When dichotomizing according to neck pain at baseline in those who underwent the HECO examinations, the results from the pain group showed a strong trend towards improvements regarding clinical diagnoses ( p = 0.006), and a significant improvement in work ability ( p = 0.002) in the intervention group, compared to the reference group (Table 4 ).

As a result, we observed a strong trend toward a poorer prognosis among patients with higher gene expression of CD93 (P = 0.006).

The Log‐rank test was significant ( χ 2 = 10.68, p = 0.0136), and the trend test showed a strong trend ( p = 0.0069).

Following that, the DESTINY-Breast03 ( NCT03529110 ) phase III trial found that T-DXd as a second-line treatment for patients with HER2-positive MBC significantly improved PFS and had a strong trend of OS benefit (HR, 0.55; 95% CI, 0.36 to 0.86; P = 0.007) when compared to T-DM1 (HR, 0.28; 95% CI, 0.22 to 0.37; P < 0.001) [ 14 ].

Survival advantage of NF–RT showed a a strong trend in both univariate (OS HR = 0.47, 95 % CI 0.28–0.82; p = 0.007) and multivariate models (OS HR = 0.57, 95 % CI 0.33–1.00, 0.051).

A strong trend for OS benefit was also observed favoring the T-DXd arm (HR 0.56, 95% CI 0.36-0.86, P = 0.0071).

A strong trend ( p = 0.0077) toward a difference in the age of onset was largely driven by the small subgroup with monoclonal gammopathy (type 5), which were older than the others (in agreement with the higher incidence of gammopathies in older patients).

ERBB2 ‐mutated tumors displayed a strong trend toward concurrent high TMB and high PD‐L1 expression (Fisher exact test, p = .0079; p adj = .056) (Figure 3 ).

For peak 2, however, this effect only showed a strong trend towards significance (p = 0.0079), which failed to remain significant after Bonferroni correction.

Although none of the SNPs reached formal statistical significance for the eight loci tested at p < 0.006, two SNPs showed a strong trend towards association with p ≤ 0.008 (Table 4 ).

In the weighted Cox proportional hazards model, on univariate analysis of survival, high preoperative WBC count was associated with a strong trend toward worse OS (HR 1.14; 95% CI 1.034–1.256; p = 0.008).